Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transducin beta-like 1 X-linked receptor 1 pseudogene is a nonfunctional DNA sequence in the human genome with sequence similarity to the TBL1XR1 gene, a member of the WD40 repeat-containing family. Pseudogenes such as this may arise through retrotransposition or duplication but generally lack coding potential and biological activity. They do not encode active proteins and thus are not considered drug targets, biomarkers, or therapeutic agents. The functional TBL1XR1 gene encodes a co-activator of nuclear hormone receptors and is associated with several diseases, but the pseudogene has no established biological or clinical relevance[5][1][3].\n\nIf information regarding the protein-coding gene TBL1XR1 is the user's actual focus, please clarify, as the protein-coding gene has clinical and functional significance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transducin beta-like 1 X-linked receptor 1 pseudogene.